Contract Pharma: AbSci Acquires Cell Therapy Company Totient
Jun 17, 2021
Totient, a biotech company harnessing human immune responses to identify novel antibodies and their therapeutic targets, has been acquired by Absci. Read more.
Jun 17, 2021
Totient, a biotech company harnessing human immune responses to identify novel antibodies and their therapeutic targets, has been acquired by Absci. Read more.